Health and Medicine

October 28, 2014

Peptide quells “genomic storm”

A cell-penetrating peptide developed at Vanderbilt blocks the signaling pathways that lead to lethal shock caused by bacterial infection.

By T.J. Utset
October 24, 2014

Immune cells’ role in hypertension

Vanderbilt researchers have discovered that certain immune cells contribute to the development of hypertension, suggesting novel targets for treating the disease.

By Leigh MacMillan
October 23, 2014

ResearchMatch database includes sub-registry for rare sarcoidosis

All ResearchMatch volunteers who self-report as having sarcoidosis will be prompted to answer additional questions to enhance the matching of volunteers with research teams who are studying this condition.

By Paul Govern
October 23, 2014

VICC investigators earn breast cancer grants

The grants, which total $830,000, are part of the non-profit organization’s commitment to young scientists, as well as established investigators who are searching for more effective breast cancer therapies.

By VUMC News and Communications
October 23, 2014

New view of transporter dynamics

New insights to the workings of a protein that moves neurotransmitters across the nerve cell membrane could aid the design of more effective antidepressants.

By Bill Snyder
October 23, 2014

‘Darting’ mice may hold clues to ADHD, autism and bipolar disorder

The transgenic mouse, into which was inserted a rare human genetic variation in the dopamine transporter, could lead to improvements in the diagnosis and treatment of these all-too-common brain disorders.

By Bill Snyder
October 20, 2014

New faculty: Dugan explores complexities of Alzheimer’s

Laura Dugan strives to bring breakthroughs in neuroscience research and the aging brain together.
By Nancy Humphrey
October 16, 2014

Staph ‘gangs’ share nutrients during infection: study

Antibiotic-resistant bacteria can share resources to cause chronic infections, Vanderbilt investigators have discovered. The findings shed light on a long-standing question in infectious diseases and may inform new treatment strategies.
By Leigh MacMillan
October 16, 2014

VUSN study seeks to improve lymphedema care

A new Vanderbilt University School of Nursing (VUSN) study may lead to earlier detection and better outcomes for the 20-30 percent of breast cancer patients with lymphedema, the painful and stigmatizing arm swelling that often results from treatment.
By VUMC News and Communications
October 16, 2014

Lymphocyte study reveals obesity clues

Vanderbilt University researchers are closer to understanding the link between obesity, chronic inflammation and type 2 diabetes.
By Bill Snyder
October 15, 2014

Antibiotics, fetal vessel defect linked

Certain antibiotics increase the risk of a congenital heart disorder called patency of the ductus arteriosis.
By VUMC News and Communications
October 14, 2014

Neuronal culprit in genetic disease

A particular neuronal cell population is involved in the pathogenesis of a rare neurological disorder, Vanderbilt researchers have discovered.
By Leigh MacMillan
October 13, 2014

New faculty: Neal will train next generation of nurse-midwives

Cesarean delivery is the most common major surgery in the United States. Although sometimes necessary for the health of mother or child, Jeremy Neal thinks too many C-sections are done without good rationale, contributing to adverse health outcomes.
By VUMC News and Communications
1 … 132 133 134 135 136 … 197